日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ex vivo imaging-based high content phenotyping of patients with rheumatoid arthritis

基于离体成像的类风湿关节炎患者高内涵表型分析

Felix Kartnig, Michael Bonelli, Ulrich Goldmann, Noemi Mészáros, Nikolaus Krall, Daniel Aletaha, Leonhard X Heinz, Giulio Superti-Furga

A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-inflammatory activity

一种具有TASL蛋白稳态抗炎活性的SLC15A4构象锁定抑制剂

Andras Boeszoermenyi ,Léa Bernaleau # ,Xudong Chen # ,Felix Kartnig ,Min Xie ,Haobo Zhang ,Sensen Zhang ,Maeva Delacrétaz ,Anna Koren ,Ann-Katrin Hopp ,Vojtech Dvorak ,Stefan Kubicek ,Daniel Aletaha ,Maojun Yang ,Manuele Rebsamen ,Leonhard X Heinz ,Giulio Superti-Furga

Advanced immunophenotyping: A powerful tool for immune profiling, drug screening, and a personalized treatment approach

高级免疫表型分析:用于免疫分析、药物筛选和个性化治疗的强大工具

Teresa Preglej ,Marie Brinkmann ,Günter Steiner ,Daniel Aletaha ,Lisa Göschl ,Michael Bonelli

In vitro evaluation of disease-modifying antirheumatic drugs against rheumatoid arthritis associated pathogens of the oral microflora

体外评价抗风湿药物对口腔菌群类风湿关节炎相关病原体的作用

Manuel Kussmann, Markus Obermueller, Kathrin Spettel, Stefan Winkler, Daniel Aletaha